UMIN-CTR History

BACK TOP
UMIN-CTR English Home Glossary (Simple) FAQ Search clinical trials

Name:
UMIN ID:

Unique ID issued by UMIN UMIN000003283
Receipt No. R000003873
Scientific Title A randomized study of Docetaxel + Cyclophosphamide (TC), 5-fluorouracil + Epirubicin + Cyclophosphamide (FEC)-TC and TC-FEC as preoperative chemotherapy for hormone receptor positive and HER2 negative primary breast cancer JBCRG-09
Date of disclosure of the study information 2010/03/03
Last modified on 2019/11/21 17:02:20

No. Disposal Last modified on Item of update
1 Insert 2010/03/02 23:21:13
2 Update 2010/03/03 11:28:09 Date of disclosure of the study information
3 Update 2011/11/28 15:52:40 Last follow-up date
4 Update 2012/05/16 13:50:16 Post marketing survey by drug manufacture etc., specified by Japanese law.
Institutions
5 Update 2012/09/02 17:54:17 Recruitment status
6 Update 2014/10/02 09:58:24 TEL
Email
Address
Address
TEL
Institute
Organization
Address2
Tel2
Institutions
7 Update 2016/07/08 15:09:01 Name of primary sponsor
Organization
8 Update 2017/09/06 09:08:18 Last follow-up date
9 Update 2018/08/23 17:36:32 Public title
10 Update 2018/08/24 10:04:27 UMIN ID1
11 Update 2019/03/28 15:47:46 Recruitment status
Date of IRB
Anticipated trial start date
12 Update 2019/11/21 17:02:20 1st name of lead principal investigator
Last name of lead principal investigator
1st name of lead principal investigator
Last name of lead principal investigator
Organization
Organization
Division name
Division name
Zip code
Address
Address

Last name of contact person

Last name of contact person
Organization
Zip code
Address
Homepage URL
Institute
Organization
Organization
Organization
Address
Address
Tel
Email


Contact us.